Sector: Healthcare|Industry: Medical Care Facilities|Market Cap: $12.43B|Employees: 70K
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Total consolidated revenues increased from $8,994.4 million for the nine months ended September 30, 2023 to $9,520.9 million for the nine months ended September 30, 2024. This increase was driven by growth in both U.S. dialysis and other ancillary services revenues.
Net income attributable to DaVita Inc. increased from $540.9 million for the nine months ended September 30, 2023 to $677.0 million for the nine months ended September 30, 2024. This increase was driven by higher operating income, partially offset by higher debt expense and other losses.
Total operating expenses increased from $7,781.5 million for the nine months ended September 30, 2023 to $7,995.7 million for the nine months ended September 30, 2024. This increase was primarily driven by higher patient care costs and general and administrative expenses.